Zechner D - Search Results

1

Diabetes increases pancreatic fibrosis during chronic inflammation.

Zechner D, Knapp N, Bobrowski A, Radecke T, Genz B, Vollmar B. Zechner D, et al. Exp Biol Med (Maywood). 2014 Jun;239(6):670-6. doi: 10.1177/1535370214527890. Exp Biol Med (Maywood). 2014. PMID: 24719378

2

Darbepoetin-α inhibits the perpetuation of necro-inflammation and delays the progression of cholestatic fibrosis in mice.

Sigal M, Siebert N, Zechner D, Menschikow E, Abshagen K, Vollmar B, Eipel C. Sigal M, et al. Among authors: zechner d. Lab Invest. 2010 Oct;90(10):1447-56. doi: 10.1038/labinvest.2010.115. Epub 2010 Jun 21. Lab Invest. 2010. PMID: 20567234 Free article.

3

Erythropoietin improves skin wound healing and activates the TGF-β signaling pathway.

Siebert N, Xu W, Grambow E, Zechner D, Vollmar B. Siebert N, et al. Among authors: zechner d. Lab Invest. 2011 Dec;91(12):1753-65. doi: 10.1038/labinvest.2011.125. Epub 2011 Sep 5. Lab Invest. 2011. PMID: 21894148 Free article.

4

Diabetes aggravates acute pancreatitis and inhibits pancreas regeneration in mice.

Zechner D, Spitzner M, Bobrowski A, Knapp N, Kuhla A, Vollmar B. Zechner D, et al. Diabetologia. 2012 May;55(5):1526-34. doi: 10.1007/s00125-012-2479-3. Epub 2012 Feb 12. Diabetologia. 2012. PMID: 22327285

5

Risk factors for pancreatic ductal adenocarcinoma specifically stimulate pancreatic duct glands in mice.

Bobrowski A, Spitzner M, Bethge S, Mueller-Graf F, Vollmar B, Zechner D. Bobrowski A, et al. Among authors: zechner d. Am J Pathol. 2013 Mar;182(3):965-74. doi: 10.1016/j.ajpath.2012.11.016. Am J Pathol. 2013. PMID: 23438477 Free article.

6

Impact of hyperglycemia and acute pancreatitis on the receptor for advanced glycation endproducts.

Zechner D, Sempert K, Genz B, Timm F, Bürtin F, Kroemer T, Butschkau A, Kuhla A, Vollmar B. Zechner D, et al. Int J Clin Exp Pathol. 2013 Sep 15;6(10):2021-9. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24133579 Free PMC article.

7

Diabetes increases pancreatitis induced systemic inflammation but has little effect on inflammation and cell death in the lung.

Zechner D, Spitzner M, Müller-Graff T, Vollmar B. Zechner D, et al. Int J Exp Pathol. 2014 Dec;95(6):411-7. doi: 10.1111/iep.12103. Epub 2014 Nov 17. Int J Exp Pathol. 2014. PMID: 25401425 Free PMC article.

8

Impact of diabetes type II and chronic inflammation on pancreatic cancer.

Zechner D, Radecke T, Amme J, Bürtin F, Albert AC, Partecke LI, Vollmar B. Zechner D, et al. BMC Cancer. 2015 Feb 13;15:51. doi: 10.1186/s12885-015-1047-x. BMC Cancer. 2015. PMID: 25885700 Free PMC article.

9

Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancer.

Zechner D, Bürtin F, Amme J, Lindner T, Radecke T, Hadlich S, Kühn JP, Vollmar B. Zechner D, et al. Cell Biosci. 2015 Aug 28;5:51. doi: 10.1186/s13578-015-0038-6. eCollection 2015. Cell Biosci. 2015. PMID: 26322225 Free PMC article.

10

Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin.

Zechner D, Bürtin F, Albert AC, Zhang X, Kumstel S, Schönrogge M, Graffunder J, Shih HY, Müller S, Radecke T, Jaster R, Vollmar B. Zechner D, et al. Oncotarget. 2016 Aug 30;7(35):56395-56407. doi: 10.18632/oncotarget.10892. Oncotarget. 2016. PMID: 27486761 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters